|$ in millions, except EPS amounts||Second Quarter 2012||Second Quarter 2011|
|Non-GAAP EPS that excludes items listed below 1||1.05||0.95|
|GAAP Net Income 2||1,793||2,024|
|Non-GAAP Net Income that excludes items listed below 1,2||3,227||2,950|
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2012.
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $1.05 exclude acquisition-related costs and restructuring costs.